FDA approves drug to treat river blindness developed by Australian organisation

episode

Health Report - Separate stories podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A Blue Wave?, Xi’s Visit, Trump vs. the Press, Diesel Prices 55 min · 26 Sep 2026 · The Politics Guys

Introducing What Could Go Right? 1 min · 26 Sep 2026 · The Politics Guys

What is Utopia? Presenting The Receipt Horizon, by Joel Borgen – Chapters 1–4 2h 50m · 26 Sep 2026 · "The Cognitive Revolution"

Science with Luke: Ultra-Processed Food 10 min · 26 Sep 2026 · The Pat Kenny Show

NPR News: 09-26-2026 7AM EDT 4 min · 26 Sep 2026 · NPR News Now

7AM ET 09/26/2026 Newscast 3 min · 26 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded18 Jun 2018

Publisherabc.net.au ↗

Handlerec:20488934

Show notes

The drug, moxidectin, could help the fight against river blindness, which is a leading global cause of preventable blindness.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in